DMAC – diamedica therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

DMAC

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

09:28 am

dmac

Rating for DMAC

Medium Report

Rating for DMAC

Report

11/14

09:14 am

dmac

DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Medium Report

DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Report

11/14

08:08 am

dmac

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

High Report

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

Report

11/14

06:19 am

dmac

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

Medium Report

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.